DexCom (DXCM): Valuation in Focus After Q2 Revenue Beat and Cautious Outlook on Sector Tensions

DexCom (DXCM) shares are in the spotlight after the company delivered better-than-expected second quarter revenues. However, a softer full-year outlook has drawn investor caution. Sector-wide trade ...